Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicenter Phase III Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients (HILARIA)

NCT04729517 is registered in ClinicalTrials.gov with Abdi Ibrahim Ilac San. ve Tic A.S. as lead sponsor.

NCT NCT04729517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicenter Phase III Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients (HILARIA)
Lead sponsor
Abdi Ibrahim Ilac San. ve Tic A.S.
Phase
Phase 3
Overall status
Completed
Start date
April 20, 2021
Completion date
May 2, 2023
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis due to allergens